(Q28269080)

1

0 references

Andreas Janzer

2

0 references

Astrid Becker

3

0 references

Andreas Zimmer

4

0 references

Reinhard Buettner

6

0 references

Jutta Kirfel

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

7

0 references

language of work or name

English

0 references

publication date

March 2010

0 references

published in

Carcinogenesis

0 references

volume

31

0 references

issue

3

0 references

page(s)

512-20

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

An epigenetic road map for histone lysine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Histone demethylation by a family of JmjC domain-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Regulation of LSD1 histone demethylase activity by its associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Opposing LSD1 complexes function in developmental gene activation and repression programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and beta-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

The Myc target gene JPO1/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Prognostic impact of Skp2 and p27 in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

The genomic profile of HER2-amplified breast cancers: the influence of ER status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

LSD1: oxidative chemistry for multifaceted functions in chromatin regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Carcinogen-induced histone alteration in normal human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Induction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

p21 in cancer: intricate networks and multiple activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Clinicopathologic significance and prognostic role of cyclin E and cyclin A expression in laryngeal epithelial lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324

Epigenomics and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP324